Advertisement

Topics

Reset Therapeutics Company Profile

23:18 EST 10th December 2018 | BioPortfolio

Reset Therapeutics is a privately held biopharmaceutical company focused on harnessing the power of the body’s internal molecular clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications. Molecular clocks are the foundation of the body’s circadian system, which synchronizes many biological processes with cycles of light, activity, and nutrient status. Founded in 2008 by leaders in the field of molecular clock biology and Bay City Capital, the company has unparalleled expertise and intellectual property related to molecular clocks and the roles that they play in health and disease.


News Articles [724 Associated News Articles listed on BioPortfolio]

Sandoz, Pear Therapeutics launch reSET prescription digital therapeutic for SUD

Study results from a multicenter, randomized clinical trial showed that reSET, when used with outpatient therapy and contingency management, significantly improved abstinence in substances of abuse an...

Sandoz, Pear Therapeutics introduce reSET for patients with substance use disorder

Sandoz, a Novartis division, and Pear Therapeutics, Inc., announced the commercial launch of reSET for patients with Substance Use Disorder (SUD).

FDA clears Novartis, Pear Therapeutics' prescription digital therapeutic for opioid use disorder reSET-O https://bit.ly/2QlGHUM 

FDA clears Novartis, Pear Therapeutics' prescription digital therapeutic for opioid use disorder reSET-O https://bit.ly/2QlGHUM 

Pear Therapeutics to Participate in Evercore ISI HEALTHCONx Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Ope...

Pear Therapeutics to Present at Jefferies 2018 Healthcare Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO, will present at the Jefferies 2018 Hea...

Pear Therapeutics Presents New Data on reSET® and reSET-O™ at American Academy of Addiction Psychiatry Annual Meeting and Scientific Symposium

New analysis of randomized clinical trial data for reSET demonstrate two-fold increase in abstinence and treatment retention for patients with Substance Use Disorder; highlight si...

With $1.6B Mazor Robotics buy, Medtronic Spine hits reset button

An expensive failed acquisition, sales force flux, off-label use of a controversial

Pear Therapeutics to Present at Canaccord Genuity 38th Annual Growth Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO, will present at the Canaccord Genuity ...

PubMed Articles [484 Associated PubMed Articles listed on BioPortfolio]

Fast and Unconditional All-Microwave Reset of a Superconducting Qubit.

Active qubit reset is a key operation in many quantum algorithms, and particularly in quantum error correction. Here, we experimentally demonstrate a reset scheme for a three-level transmon artificial...

The immune system as a sensorial system that can modulate brain functions and reset homeostasis.

Evidence indicates that activated immune cells release products, typically cytokines, that can convey information to the brain about the type of ongoing peripheral immune responses. This evidence led ...

Period-adding bifurcation and chaos in a hybrid Hindmarsh-Rose model.

Recently, the hybrid neuron models which combine the basic neuron models with impulsive effect(the state reset process) had been proposed, however, the preset value and the reset value of membrane pot...

Periodic flashing coordinated reset stimulation paradigm reduces sensitivity to ON and OFF period durations.

Pathological synchronization in the basal ganglia network has been considered an important component of Parkinson's disease pathophysiology. An established treatment for some patients with Parkinson's...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Clinical Trials [183 Associated Clinical Trials listed on BioPortfolio]

Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

Type 1 diabetes is an autoimmune disease characterized by destruction of pancreatic beta-cells, resulting in absolute deficiency of insulin. Presently there is no known cure. Our proposed...

Clinical Investigation on the Acoustic Stimulation in the Treatment of Chronic Tinnitus

There are many treatments for chronic tinnitus that have been claimed, with varying degrees of statistical reliability. None of those treatments can eradicate the tinnitus completely. Some...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1285 Associated Companies listed on BioPortfolio]

Reset Therapeutics, Inc.

Reset, a discovery-stage biopharma company co-founded by leaders in the field of circadian biology and Bay City Capital, is developing first-in-class approaches to treating diseas...

Reset Therapeutics

Reset Therapeutics is a privately held biopharmaceutical company focused on harnessing the power of the body’s internal molecular clocks to discover, develop, and commerciali...

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approv...

American Institute of Chemical Engineers (AIChE)

AIChE is enhancing its website and database security policies which require that the security features currently in place be updated. Registered passwords will be reset on Sunday, July 8. Registered ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Reset Therapeutics" on BioPortfolio

We have published hundreds of Reset Therapeutics news stories on BioPortfolio along with dozens of Reset Therapeutics Clinical Trials and PubMed Articles about Reset Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reset Therapeutics Companies in our database. You can also find out about relevant Reset Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record